Implementation of Intraperitoneal Chemotheraphy for the Treatment of Ovarian Cancer

Catherine Hydzik

hyperthermic intraperitoneal chemotherapy, Patient education
CJON 2007, 11(2), 221-225. DOI: 10.1188/07.CJON.221-225

In January 2006, a clinical announcement made by the National Cancer Institute suggested that intraperitoneal chemotherapy become standard care for patients with newly diagnosed stage III, optimally debulked epithelial ovarian cancer. Intraperitoneal chemotherapy is new to many healthcare providers (i.e., physicians, nurses, and pharmacists). This article will discuss how to implement intraperitoneal chemotherapy in practice. Education and experience are the keys to successful implementation.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.